Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Global medical technology company Inspiration Healthcare said it expects slightly lifted its guidance on revenue amid a 'record' year of growth.
The company previously said it expected to top market expectations with revenues to exceed £36.5 million, but now it anticipates reporting revenue of approximately £36.8 million representing an increase of 52% compared to the prior financial year.
The slightly uptick in revenue guidance was attributed to the inclusion of SLE, Viomedex and the 'one time' ventilator orders relating to Covid-19 in the UK.
Earnings before interest, tax, depreciation, amortisation, share based payments and exceptional items, or EBITDA, was expected to be not less than £4.9 million, representing growth of more than 53% over the prior financial year, the company said, maintaining its previous guidance.
The company confirmed that the group had 'achieved a record turnover in the last financial year against a backdrop of uncertainty caused by the Covid-19 pandemic and Brexit.'
At 9:04am: (LON:IHC) Inspiration Healthcare Group share price was 0p at 80.5p